Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.
C4 Therapeutics Announces Publication in Nature Chemical Biology on Degradation Technologies Licensed from Dana-Farber Cancer Institute
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
©2021 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Tidal Media Group